Towards the fag end of the previous week, the tensions between the US and Iran arose from nowhere and the small trailer of it was seen on Friday (January 03) itself. However, the real repercussion of this development was seen on the first trading day of the week gone by. We had a massive cut of nearly two percent to test sub-12,000 levels. This continued till Wednesday’s opening point as things started to look extremely scary. Fortunately, things cooled off with respect to this as no follow up action was seen from both countries thereafter. This resulted into a V-shaped recovery in our market after an overreaction seen in the first half. Eventually, Nifty managed to close in the positive territory and is now knocking on the doors for new milestones.
View – Bullish
Last Close – Rs. 574.15
Justification – After trading in a broad range of 530-560 for the last month, the stock has broken above the higher range, confirming a bullish range breakout. The last two sessions’ up-move is supported with a bullish gap and with increasing volume. In addition, the lead indicator RSI has hastened into the positive zone from the oversold zone suggesting a strong positive momentum. In the last few weeks, stocks from the midcap segments have been outperforming and going with all the above rationale, this stock too seems to be gearing up for a strong up move in the near term. Thus, we recommend buying this stock on a minor decline for a target of Rs.640 over the next days. The stop loss should be fixed at Rs.536.
INDOCO REMEDIES (INDOCO)
View – Bullish
Last Close – Rs. 195.50
Justification – After a long time, midcap stocks have finally joined the bull’s party and showed outperformance during the week gone by. This midcap stock, after gyrating in a broad range of 135-175 for the last five months, finally broke the range last week on the higher side, confirming a ‘Rectangular Channel’ breakout. In addition, prices on the daily chart have also closed above SUPER TREND indicator which acted as stiff resistance four times in the last few months. Moreover, we are also witnessing a fresh bullish crossover with 50EMA crossing 89-EMA from below, supporting the buy call. Looking at the favorable risk-reward ratio, traders are advised to go long for the target of Rs. 211 over the next few days. The stop-loss should be fixed at Rs.186.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)